SCHEMBL736833

SCHEMBL736833

O=CN[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H](Cc1csc2ccccc12)NC(=O)C1CCNCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.59
CAPN1 P07384 1/20 0.39
OPRM1 P35372 1/20 0.39
MC4R P32245 3/20 0.38
MC3R P41968 2/20 0.38
MC1R Q01726 2/20 0.38
CALCRL Q16602 1/20 0.38
MTNR1A P48039 1/20 0.37
PLG P00747 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
KLKB1 P03952 2/20 0.35
KLK1 P06870 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739280 0.97 GHSR (0.59) GHSRCAPN1OPRM1MC4RMC3R
SCHEMBL737028 0.91 GHSR (0.70) GHSROPRM1CALCRLMTNR1AMMP2
SCHEMBL738947 0.90 GHSR (0.59) GHSRCAPN1MC4RMC3RMC1R
SCHEMBL737983 0.89 GHSR (0.63) GHSROPRM1CALCRLMTNR1APLG
SCHEMBL737982 0.89 GHSR (0.63) GHSROPRM1CALCRLMTNR1APLG
SCHEMBL739671 0.87 GHSR (0.59) GHSRCAPN1MC4RMC3RMC1R
SCHEMBL736832 0.86 GHSR (0.60) GHSROPRM1MC4RMC3RMC1R
SCHEMBL736960 0.84 GHSR (0.84) GHSROPRM1CALCRL
SCHEMBL739061 0.84 GHSR (0.84) GHSROPRM1CALCRL
SCHEMBL14615567 0.84 GHSR (0.52) GHSROPRM1MC1RCALCRLMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed
WO-2007014258-A2 GROWTH HORMONE SECRETAGOGUES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) 2007-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM GHSR 1/4885CAPN1 3316/4885OPRM1 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.